You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 11, March 16, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Randomized Controlled Trial
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer

A Randomized Controlled Trial

The HOPE and HOPE-TOO Trial Investigators*

JAMA. 2005;293:1338-1347.

Context  Experimental and epidemiological data suggest that vitamin E supplementation may prevent cancer and cardiovascular events. Clinical trials have generally failed to confirm benefits, possibly due to their relatively short duration.

Objective  To evaluate whether long-term supplementation with vitamin E decreases the risk of cancer, cancer death, and major cardiovascular events.

Design, Setting, and Patients  A randomized, double-blind, placebo-controlled international trial (the initial Heart Outcomes Prevention Evaluation [HOPE] trial conducted between December 21, 1993, and April 15, 1999) of patients at least 55 years old with vascular disease or diabetes mellitus was extended (HOPE–The Ongoing Outcomes [HOPE-TOO]) between April 16, 1999, and May 26, 2003. Of the initial 267 HOPE centers that had enrolled 9541 patients, 174 centers participated in the HOPE-TOO trial. Of 7030 patients enrolled at these centers, 916 were deceased at the beginning of the extension, 1382 refused participation, 3994 continued to take the study intervention, and 738 agreed to passive follow-up. Median duration of follow-up was 7.0 years.

Intervention  Daily dose of natural source vitamin E (400 IU) or matching placebo.

Main Outcome Measures  Primary outcomes included cancer incidence, cancer deaths, and major cardiovascular events (myocardial infarction, stroke, and cardiovascular death). Secondary outcomes included heart failure, unstable angina, and revascularizations.

Results  Among all HOPE patients, there were no significant differences in the primary analysis: for cancer incidence, there were 552 patients (11.6%) in the vitamin E group vs 586 (12.3%) in the placebo group (relative risk [RR], 0.94; 95% confidence interval [CI], 0.84-1.06; P = .30); for cancer deaths, 156 (3.3%) vs 178 (3.7%), respectively (RR, 0.88; 95% CI, 0.71-1.09; P = .24); and for major cardiovascular events, 1022 (21.5%) vs 985 (20.6%), respectively (RR, 1.04; 95% CI, 0.96-1.14; P = .34). Patients in the vitamin E group had a higher risk of heart failure (RR, 1.13; 95% CI, 1.01-1.26; P = .03) and hospitalization for heart failure (RR, 1.21; 95% CI, 1.00-1.47; P = .045). Similarly, among patients enrolled at the centers participating in the HOPE-TOO trial, there were no differences in cancer incidence, cancer deaths, and major cardiovascular events, but higher rates of heart failure and hospitalizations for heart failure.

Conclusion  In patients with vascular disease or diabetes mellitus, long-term vitamin E supplementation does not prevent cancer or major cardiovascular events and may increase the risk for heart failure.



Authors/Writing Committee: Eva Lonn, MD, MSc, Jackie Bosch, MSc, Salim Yusuf, MBBS, DPhil, Patrick Sheridan, MSc, Janice Pogue, MSc (Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario); J. Malcolm O. Arnold, MD (Department of Medicine, University of Western Ontario, London, Ontario); Catherine Ross, MD, Andrew Arnold, MBBS (Department of Medicine and Medical Oncology, McMaster University, Hamilton, Ontario); Peter Sleight, MD, DM (Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford University, Oxford, England); Jeffrey Probstfield, MD (University of Washington, School of Medicine, Seattle); and Gilles R. Dagenais, MD (Institut Cardiologiede, University Laval, Ste-Foy, Quebec).


RELATED LETTERS

Vitamin E Supplementation, Cardiovascular Events, and Cancer
Robert M. Richey
JAMA. 2005;294(4):425.
EXTRACT | FULL TEXT  

Vitamin E Supplementation, Cardiovascular Events, and Cancer
Alan R. Gaby
JAMA. 2005;294(4):425.
EXTRACT | FULL TEXT  

Vitamin E Supplementation, Cardiovascular Events, and Cancer
Robert W. Jarski, Kenneth R. Hightower, and Michael I. Dangovian
JAMA. 2005;294(4):425-426.
EXTRACT | FULL TEXT  

Vitamin E Supplementation, Cardiovascular Events, and Cancer—Reply
Eva Lonn
JAMA. 2005;294(4):426.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Is There Any Hope for Vitamin E?
B. Greg Brown and John Crowley
JAMA. 2005;293(11):1387-1390.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prolonged administration of a dithiol antioxidant protects against ventricular remodeling due to ischemia-reperfusion in mice
Ambler et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;295:H1303-H1310.
ABSTRACT | FULL TEXT  

Age-Related Macular Degeneration
Jager et al.
NEJM 2008;358:2606-2617.
FULL TEXT  

Statin Treatment as a Confounding Factor in Human Trials with Vitamin E
Violi and Cangemi
J. Nutr. 2008;138:1179-1181.
ABSTRACT | FULL TEXT  

Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
Murphy and Steenbergen
Physiol. Rev. 2008;88:581-609.
ABSTRACT | FULL TEXT  

Primary prevention of coronary heart disease in women
Rees et al.
Menopause Int 2008;14:40-45.
ABSTRACT | FULL TEXT  

Dual Therapy With Statins and Antioxidants Is Superior to Statins Alone in Decreasing the Risk of Cardiovascular Disease in a Subgroup of Middle-Aged Individuals With Both Diabetes Mellitus and the Haptoglobin 2-2 Genotype
Blum et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:e18-e20.
FULL TEXT  

Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype: A Prospective Double-Blinded Clinical Trial
Milman et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:341-347.
ABSTRACT | FULL TEXT  

Protective Effect of Dietary Potassium Against Vascular Injury in Salt-Sensitive Hypertension
Kido et al.
Hypertension 2008;51:225-231.
ABSTRACT | FULL TEXT  

Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E
Cangemi et al.
Eur Heart J 2008;29:54-62.
ABSTRACT | FULL TEXT  

Role of Oxidants and Antioxidants in Atherosclerosis: Results of In Vitro and In Vivo Investigations
Siekmeier et al.
J CARDIOVASC PHARMACOL THER 2007;12:265-282.
ABSTRACT  

Primary prevention of age related macular degeneration
Evans
BMJ 2007;335:729-729.
FULL TEXT  

Effects of Random Allocation to Vitamin E Supplementation on the Occurrence of Venous Thromboembolism: Report From the Women's Health Study
Glynn et al.
Circulation 2007;116:1497-1503.
ABSTRACT | FULL TEXT  

Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study
Key et al.
Am. J. Clin. Nutr. 2007;86:672-681.
ABSTRACT | FULL TEXT  

Evolution of medical treatment for endometriosis: back to the roots?
Wieser et al.
Hum Reprod Update 2007;13:487-499.
ABSTRACT | FULL TEXT  

Lung Cancer Chemoprevention: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Gray et al.
Chest 2007;132:56S-68S.
ABSTRACT | FULL TEXT  

A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in Women: Results From the Women's Antioxidant Cardiovascular Study
Cook et al.
Arch Intern Med 2007;167:1610-1618.
ABSTRACT | FULL TEXT  

Supplemental and Dietary Vitamin E Intakes and Risk of Prostate Cancer in a Large Prospective Study
Wright et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1128-1135.
ABSTRACT | FULL TEXT  

Serum and Dietary Vitamin E in Relation to Prostate Cancer Risk
Weinstein et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1253-1259.
ABSTRACT | FULL TEXT  

Nuclear Factor-{kappa}B, p38, and Stress-Activated Protein Kinase Mitogen-Activated Protein Kinase Signaling Pathways Regulate Proinflammatory Cytokines and Apoptosis in Human Placental Explants in Response to Oxidative Stress: Effects of Antioxidant Vitamins
Cindrova-Davies et al.
Am. J. Pathol. 2007;170:1511-1520.
ABSTRACT | FULL TEXT  

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing
McCrindle et al.
Circulation 2007;115:1948-1967.
ABSTRACT | FULL TEXT  

Deficiency of Glutathione Peroxidase-1 Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
Torzewski et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:850-857.
ABSTRACT | FULL TEXT  

Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-analysis
Bjelakovic et al.
JAMA 2007;297:842-857.
ABSTRACT | FULL TEXT  

Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Takimoto and Kass
Hypertension 2007;49:241-248.
FULL TEXT  

Heart disease and single-vitamin supplementation
Traber
Am. J. Clin. Nutr. 2007;85:293S-299S.
ABSTRACT | FULL TEXT  

The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
Dzau et al.
Circulation 2006;114:2850-2870.
FULL TEXT  

Rethinking Primary Prevention of Atherosclerosis-Related Diseases
Napoli et al.
Circulation 2006;114:2517-2527.
FULL TEXT  

Dietary flavonoids with a catechol structure increase {alpha}-tocopherol in rats and protect the vitamin from oxidation in vitro
Frank et al.
J. Lipid Res. 2006;47:2718-2725.
ABSTRACT | FULL TEXT  

Heart outcomes prevention evaluation-the ongoing outcomes study, vitamin e, and age-related macular degeneration.
Pulido
Arch Ophthalmol 2006;124:1665-1665.
FULL TEXT  

Heart Outcomes Prevention Evaluation-The Ongoing Outcomes Study, Vitamin E, and Age-Related Macular Degeneration--Reply
Chew and Clemons
Arch Ophthalmol 2006;124:1665-1666.
FULL TEXT  

A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins.
Zhang et al.
Am. J. Clin. Nutr. 2006;84:912-919.
ABSTRACT | FULL TEXT  

Summary of American Heart Association Diet and Lifestyle Recommendations Revision 2006
Lichtenstein et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:2186-2191.
FULL TEXT  

American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity
Kushi et al.
CA Cancer J Clin 2006;56:254-281.
ABSTRACT | FULL TEXT  

Nutrition and Stroke Prevention
Fisher et al.
Stroke 2006;37:2430-2435.
ABSTRACT | FULL TEXT  

EUK-8, a Superoxide Dismutase and Catalase Mimetic, Reduces Cardiac Oxidative Stress and Ameliorates Pressure Overload-Induced Heart Failure in the Harlequin Mouse Mutant
van Empel et al.
J Am Coll Cardiol 2006;48:824-832.
ABSTRACT | FULL TEXT  

Role of Oxidative Stress in Remodeling of the Myocardial Microcirculation in Hypertension
Zhu et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:1746-1752.
ABSTRACT | FULL TEXT  

Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee
Lichtenstein et al.
Circulation 2006;114:82-96.
ABSTRACT | FULL TEXT  

The rust on the magic bullet
Katz
Br. J. Ophthalmol. 2006;90:811-811.
FULL TEXT  

Oxidized Forms of Glutathione in Peripheral Blood as Biomarkers of Oxidative Stress
Rossi et al.
Clin. Chem. 2006;52:1406-1414.
ABSTRACT | FULL TEXT  

Assessment of Tocopherol Metabolism and Oxidative Stress in Familial Hypobetalipoproteinemia
Clarke et al.
Clin. Chem. 2006;52:1339-1345.
ABSTRACT | FULL TEXT  

A 76-year-old man with macular degeneration.
Arroyo
JAMA 2006;295:2394-2406.
FULL TEXT  

The Maximal Amount of Dietary {alpha}-Tocopherol Intake in U.S. Adults (NHANES 2001-2002)
Gao et al.
J. Nutr. 2006;136:1021-1026.
ABSTRACT | FULL TEXT  

Biomarkers of Oxidative Damage in Human Disease
Dalle-Donne et al.
Clin. Chem. 2006;52:601-623.
ABSTRACT | FULL TEXT  

Reducing the "Risk" of Chemoprevention: Defining and Targeting High Risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
Lippman and Lee
Cancer Res. 2006;66:2893-2903.
ABSTRACT | FULL TEXT  

Optimizing the ongoing search for new treatments for Parkinson disease: Using futility designs
Tilley et al.
Neurology 2006;66:628-633.
ABSTRACT | FULL TEXT  

Aged Garlic Extract Improves Homocysteine-Induced Endothelial Dysfunction in Macro- and Microcirculation
Weiss et al.
J. Nutr. 2006;136:750S-754S.
ABSTRACT | FULL TEXT  

Vitamin E in the prevention of prostate cancer: where are we today?
Lee et al.
JNCI J Natl Cancer Inst 2006;98:225-227.
FULL TEXT  

Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.
Kirsh et al.
JNCI J Natl Cancer Inst 2006;98:245-254.
ABSTRACT | FULL TEXT  

Neither vitamin E nor donepezil delays progression from amnestic mild cognitive impairment to Alzheimer's disease in the long term
Blacker
Evid. Based Ment. Health 2006;9:20-20.
FULL TEXT  

Walnuts Reduce Aortic ET-1 mRNA Levels in Hamsters Fed a High-Fat, Atherogenic Diet
Davis et al.
J. Nutr. 2006;136:428-432.
ABSTRACT | FULL TEXT  

Supplementation with mixed tocopherols increases serum and blood cell {gamma}-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes
Clarke et al.
Am. J. Clin. Nutr. 2006;83:95-102.
ABSTRACT | FULL TEXT  

Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening--A Report From the American Society of Clinical Oncology
Herbst et al.
JCO 2006;24:190-205.
ABSTRACT | FULL TEXT  

Glucosamine-Induced Endoplasmic Reticulum Dysfunction Is Associated With Accelerated Atherosclerosis in a Hyperglycemic Mouse Model
Werstuck et al.
Diabetes 2006;55:93-101.
ABSTRACT | FULL TEXT  

Vitamin Supplements
Obstet Gynecol 2006;107:174-176.
FULL TEXT  

Kinetics of Response to Long-Term Treatment Combining Pentoxifylline and Tocopherol in Patients With Superficial Radiation-Induced Fibrosis
Delanian et al.
JCO 2005;23:8570-8579.
ABSTRACT | FULL TEXT  

Vitamin C and Vitamin E for Alzheimer's Disease
Boothby and Doering
The Annals of Pharmacotherapy 2005;39:2073-2079.
ABSTRACT | FULL TEXT  

Role of Diet in Prostate Cancer Development and Progression
Chan et al.
JCO 2005;23:8152-8160.
ABSTRACT | FULL TEXT  

Potential harm of vitamin E supplementation
Hemila
Am. J. Clin. Nutr. 2005;82:1141-1142.
FULL TEXT  

Vitamin E Supplementation in Cardiovascular Disease and Cancer Prevention: Part 1
Pham and Plakogiannis
The Annals of Pharmacotherapy 2005;39:1870-1878.
ABSTRACT | FULL TEXT  

Use of Antioxidants During Chemotherapy and Radiotherapy Should Be Avoided
D'Andrea
CA Cancer J Clin 2005;55:319-321.
ABSTRACT | FULL TEXT  

Vitamin E Supplementation, Cardiovascular Events, and Cancer
Richey
JAMA 2005;294:425-425.
FULL TEXT  

Vitamin E Supplementation, Cardiovascular Events, and Cancer
Gaby
JAMA 2005;294:425-425.
FULL TEXT  

Vitamin E Supplementation, Cardiovascular Events, and Cancer
Jarski et al.
JAMA 2005;294:425-426.
FULL TEXT  

Essential Nutrients: Food or Supplements?: Where Should the Emphasis Be?
Lichtenstein and Russell
JAMA 2005;294:351-358.
ABSTRACT | FULL TEXT  

Brief Communication: The Prevalence of High Intake of Vitamin E from the Use of Supplements among U.S. Adults
Ford et al.
ANN INTERN MED 2005;143:116-120.
ABSTRACT | FULL TEXT  

An Editorial Update: Annus horribilis for Vitamin E
Guallar et al.
ANN INTERN MED 2005;143:143-145.
FULL TEXT  

Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women's Health Study: A Randomized Controlled Trial
Lee et al.
JAMA 2005;294:56-65.
ABSTRACT | FULL TEXT  

Low-Dose Aspirin and Vitamin E: Challenges and Opportunities in Cancer Prevention
Jacobs and Thun
JAMA 2005;294:105-106.
FULL TEXT  

Some Dietary and Adipose Tissue Carotenoids Are Associated with the Risk of Nonfatal Acute Myocardial Infarction in Costa Rica
Kabagambe et al.
J. Nutr. 2005;135:1763-1769.
ABSTRACT | FULL TEXT  

From the Library
Br. J. Ophthalmol. 2005;89:930-930.
FULL TEXT  

Vitamin E Not Helpful Against Heart Disease and Cancer
JWatch Emergency Med. 2005;2005:4-4.
FULL TEXT  

Cardiovascular Risk Associated with Celecoxib
Brophy et al.
NEJM 2005;352:2648-2650.
FULL TEXT  

Mild Cognitive Impairment -- No Benefit from Vitamin E, Little from Donepezil
Blacker
NEJM 2005;352:2439-2441.
FULL TEXT  

JournalScan
Malik
Heart 2005;91:847-848.
FULL TEXT  

Vitamin E Supplementation: What to Do?
Journal Watch Dermatology 2005;2005:14-14.
FULL TEXT  

It Looks HOPEless for Vitamin E
Journal Watch Cardiology 2005;2005:2-2.
FULL TEXT  

Vitamin E Supplementation: What to Do?
JWatch General 2005;2005:1-1.
FULL TEXT  

What's new in the other general journals
Tonks
BMJ 2005;330:693-694.
FULL TEXT  

Is There Any Hope for Vitamin E?
Brown and Crowley
JAMA 2005;293:1387-1390.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.